Aquestive 制药 AQST
$3.61 −$0.05 (-1.37%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.60 -0.28%
开盘$3.71
昨收$3.66
当日区间$3.55 – $3.76
成交量4.14M
市值$453.73M
市盈率（TTM）–
股息率–
AQST 相关新闻
匹配 Aquestive Therapeutics 或代码 AQST 的头条新闻，按最新排序。
- H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10
- Lake Street Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $6
- LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10
- LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Raises Target Price to $10 正面
- Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Aquestive Therapeutics (AQST) and Alto Neuroscience, Inc. (ANRO)
- LifeSci Capital Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9
- Cantor Fitzgerald Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $11
- Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8
- A Quick Look at Today's Ratings for Aquestive Therapeutics(AQST.US), With a Forecast Between $6 to $9
- A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $9
- Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Ardent Health Partners, Inc. (ARDT)
- Piper Sandler Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $8
- Oppenheimer Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $8
- A. G. P. Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Cuts Target Price to $9 负面
- Leerink Partners Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Announces Target Price $9
暂无评论——快来第一个聊聊 AQST。